KYTHERA Biopharmaceuticals, Inc., formerly known as AESTHERx, Inc., was founded in August 2005 and is a privately held biopharmaceutical company located north of Los Angeles in southern California.
KYTHERA is focused on science and innovation in aesthetic medicine. This market is expanding rapidly driven by an aging population, increasing discretionary income, and an evolution of patient preference toward restorative and preventative care. The company uses the tools of biotechnology to develop prescription therapeutics for this emerging market.
Funding Rounds (4) - $98.4MUpdate
Current Team (18)Update
|May 10, 2016||PRNewswire UK All - Sanifit Expands Board With Senior Hire|
|Apr 29, 2016||PE HUB - ARCH leads $34 mln Series A financing in Sienna Biopharmaceuticals|
|Apr 28, 2016||SoCal - Tech - Sienna Biopharmaceuticals Gets $34M For Aesthetic Medicine Products|
|Feb 3, 2016||Xconomy - Unity Bio Wants To “Lengthen Health Span,” But 1st Goals More Modest|
|Dec 5, 2015||Democrat and Chronical - Clausen: Ex-B+L boss at center of Allergan deal|
|Nov 6, 2015||PRNewswire All - Alopecia Therapeutic Pipeline Review for H2 2015 in a Market Research Reports|
|Oct 30, 2015||Bloomberg - Behind Allergan, a Dealmaking CEO Ready to Win the Big Prize|
|Oct 29, 2015||LA Times - Allergan, Pfizer in talks for what could be biggest deal this year|
27200 West Agoura Road
Calabasas, CA 91301